ABSTRACT
INTRODUCTION
In the recent years, the study on the synthesis of Ag nanoparticles has progressed rapidly, since the materials have many potential applications. The uses of Ag nanoparticles include as antibacterial agents [1] [2] , colorimetric sensing [3] , solar cells [4] , catalysts [5] , etc. To meet the applications, the colloids of Ag nanoparticles must have suitable physical and chemical properties such as homogeneous shape, small and narrow particle size, and is stable for a long period. The Ag nanoparticles that have homogeneous globular shape and diameter of about 10-50 nm are usually needed. Also, during the application, they must be stable for a few months without forming a larger aggregate and being separated.
The preparation of the Ag nanoparticles itself is subject to intense investigation to obtain Ag nanoparticles with required physical and chemical properties. One of the many preparations of Ag nanoparticles is by chemical reduction using the reducing agents that include resorcinol [6] , chitosan [2] , and glucose [7] . They recently can also be prepared by the sonochemical method in the graphene structure [8] .
Green synthesis by use of onion extract was applied to produce Ag nanoparticles [9] .
The size, shape, and stability of the colloidal Ag nanoparticles are main considerations for their specific usages. The size, shape, and stability of the Ag nanoparticles may be controlled by use of both reducing agent and stabilizing agent. Nanoparticles produced using the reducing agent of oleylamine is stable for up to 100 days. Oleylamine is a weak reducing agent [10] , which can produce a stable colloid. Biosynthesis using Trichoderma viride produces spherical, rectangular, pentagonal and hexagonal shapes of Ag nanoparticles of different dimensions with control of physical parameters, pH, temperature, and reaction time [11] .
The capping and reducing agent are responsible for crystal growth that will determine the properties of the Ag nanoparticles [12] . So far, to the best of our knowledge, there has been no report on the effect reducing agent on the size, shape, zeta potential, and stability of the Ag nanoparticles. In this paper, we report on the effect of the reducing agent on the particle size, crystal structure, stability, and zeta potential value. The objective of the work is to better understand the relationship between the reducing agent and the important characteristics of the resulting colloids.
EXPERIMENTAL SECTION

Materials
Silver nitrate, ascorbic acid, sodium citrate, glucose, polyvinyl alcohol, and hydrazine were purchased from Merck. Sigma-Aldrich supplied sodium borohydride. The chemicals were used as received. The solutions were prepared by use of double distilled water.
Instrumentation
The UV-Vis spectra or more precisely SPR spectra of the colloids were examined using a UV-Vis Shimadzu 1700-E. A Zetasizer Nano Series Malvern particle size analyzer was used to record the particle size of the products. The image of the nanoparticles was studied using TEM JEOL JEM-1400 Transmission Electron Microscope. An XRD Rigaku Mini Flex 600 diffractometer was used to examine the crystal structure of the Ag nanoparticles.
Procedure
An aqueous solution of silver nitrate in 0.25% PVA was prepared first using distilled water. The PVA solution was heated to boil before the dissolution of silver nitrate. The concentration of the silver nitrate stock solution was 3.0×10 -4 M. A 25 mL silver nitrate solution was stirred and heated to 80 °C before the addition of the reducing agent. The concentration of the reducing agent of ascorbic acid, sodium borohydride, and hydrazine was prescribed at 1.5 to 7.5×10 -4 M. The solution of reducing agent (5 mL) was added to a 25 mL silver nitrate solution dropwise for a total of 30 min. For sodium citrate, the concentration was adjusted at 1.5 to 15×10 -2 M and for glucose was set at 0.2-0.8 M. After the addition of the reducing agent, the solution was continuously stirred for an additional hour.
The colloids were analyzed by using a UV-Vis spectrometer to determine the peak absorbance and stability with a wavelength of 200-700 nm. Colloids were also subjected to the TEM measurement for morphology analysis and particle size analysis. The nanoparticle was separated by centrifuge at a spin rate of 17000 rpm for 20 min. The powder was dried in the air at 50 °C for overnight to obtain the powder before XRD data collection. Fig. 1 shows the TEM images of the colloidal Ag nanoparticles produced in the PVA solution with different reducing agents. The particles size of Ag nanoparticles obtained by use of ascorbic acid give more uniform size with an average particle diameter of about 30 nm and spherical shape, Fig. 1(a) . When glucose is used as a reducing agent, the Ag nanoparticles average diameter is around 20 nm, which is smaller than that of Ag nanoparticles obtained by use of ascorbic acid, Fig. 1(b) . The shape of the particles is spherical, but the diameter of the particles is varied. However, the size of the particles is smaller than that of Ag nanoparticles synthesized by using ascorbic acid.
RESULT AND DISCUSSION
Alginate stabilized colloidal Ag nanoparticles produced by use of reducing agent of glucose has a particle size of 3-12 nm [13] . When glucose and polysaccharide are used in place of reducing and capping agents, the particle size is about 15 nm [7] . The data suggest that both reducing and capping agents play an essential role in the size of prepared Ag nanoparticles. Strong reducing agents give big particle size. Meanwhile, weak reducing agents produce small particle size.
The Ag nanoparticles generated in the same solution by use of sodium borohydride have an average particle size comparable to the Ag nanoparticles acquired by use of glucose as a reducing agent. However, the diameter of the particles is similar, Fig.  1(c) . When sodium citrate was used as a reducing agent, the shape and the size changed significantly. They have many forms, i.e. hexagonal, rod, and spherical, as the majority. The bar shape has the length larger than 500 nm. The Ag nanoparticles prepared using the reducing agent of hydrazine have a big particle size. The shape of the particles is mainly hexagonal and round, Fig. 1(e) . The size is larger than that of the fore-mentioned Ag nanoparticles with a diameter of more than 50 nm.
In this work, we confirmed the particle size of the Ag nanoparticles by use of a particle size analyzer. Fig. 2 shows the particle size distribution of the products obtained with several reducing agents. As previously indicated in the TEM images, the Ag nanoparticles made in the PVA solution by use of ascorbic acid have much homogeneous particle size distribution, Fig. 2(a) . It has a single dull peak. However, the Ag nanoparticles synthesized in the similar solution with reducing agent of glucose have a large particle size and different diameter, Fig. 2(b) , as indicated by the appearance of the second peak. Sodium borohydride reducing agent gives Ag nanoparticles that are much bigger than that of Ag nanoparticles made using ascorbic acid and glucose. The particle size is much varied. There are small particles appeared when sodium citrate, Fig. 2(d) . The reducing agent of hydrazine yields particles bigger than that of the particles synthesized using glucose. However, the diameter is varied, Fig. 2(e) . No small particle size are detected for reducing agent of hydrazine. Fig. 3 represents the UV-Vis spectra of colloidal Ag nanoparticles produced by using some of the reducing agents that are ascorbic acid, sodium borohydride, and hydrazine, at different series of concentration. The peak absorbance of the colloid made by using ascorbic acid bigger and narrower than that of colloid fabricated by using Fig. 3(III) . The absorbance of the colloid increases along with the increase in the concentration of Ag nanoparticles. The concentration of the reducing agent was observed to affect the spectra. The peaks shift to the larger wavelength when the concentration is raised.
The peak absorbance of the colloid created by using sodium borohydride is smaller than that of the colloid produced by using ascorbic acid. However, the peak of the absorbance shifts to the high wavelength for low concentration of reducing agent. The UV-Vis spectra are also wider for colloid reduced by using sodium borohydride, Fig. 3(II) . Similar spectra were also observed when hydrazine was used, 3(III). For reducing agent of hydrazine, the spectra are sharper for high concentration than for low concentration. Glucose and sodium citrate give UV-Vis spectra comparable to that of sodium borohydride and hydrazine (data not shown). Also, the peak absorbance for ascorbic acid is the largest of all. The UV-Vis spectra suggest that small homogeneous particles will give the absorbance at a low wavelength and sharp peak.
The value of the zeta potential can indicate the stability of the colloid. Table 1 shows the zeta potential of the colloidal Ag nanoparticles made with different reducing agents in the PVA aqueous solution. The colloid of Ag nanoparticles prepared using sodium borohydride has the zeta potential of -11.20 mV, which is the largest. Glucose, sodium citrate, and hydrazine yield colloids with comparable zeta potentials of about -4 mV. Meanwhile, the colloidal Ag nanoparticles prepared by using ascorbic acid give zeta potential close to that of sodium borohydride, which is -10.40 mV. The negative value of zeta potential suggests that the colloidal Ag nanoparticles have a net positive charge and the surrounding stabilizing agent has a net negative charge. When bovine serum albumin (BSA) was used as a capping agent to prepare Ag/BSA nanoparticles, it gave Zeta potential about -5 to -9 mV [14] . The values of zeta potential for colloids produced by the use of ascorbic acid and sodium borohydride are larger than the colloid Ag/BSA nanoparticles. The larger the zeta potential, the more stable the colloid would be.
The colloids of Ag nanoparticles are dependent on the stabilizing agents and reducing agents. The colloid can be prepared well in the dilute solution of PVA with the use of ascorbic acid and sodium borohydride. However, by considering the zeta potential, the colloid is expected to be more stable if ones use the reducing agent of sodium borohydride as reducing agent than that of the same colloids prepared by use of ascorbic acid as a reagent. The largest absolute zeta potential of the colloid is produced by using sodium borohydride. This type of colloid is very useful for long-term applications.
The XRD data determine crystalline structures of the Ag nanoparticles. Fig. 4 displays the XRD patterns of the Ag nanoparticles produced in the dilute PVA solution as a capping agent and several reducing agents. In general, the diffraction peaks correspond well to the face-centered cubic structure, fcc. The diffraction peaks appear at 2-theta of 38.093, 44.24, 64.35, 77.30, 81.43 degrees. They correspond to the Miller indices of (111), (200), (220), (311), and (222), respectively. The unit cells obtained by Bragg law are in the range 4.0906-4.0992 angstrom. Similar XRD data for Ag nanoparticles were reported previously [2] . Table 2 shows the collated unit cells of the Ag nanoparticles produced using various reducing agents. The data are confirmed by comparison with JCPDS Card No. 96-900-8460 [15] . UV-Vis spectra of colloidal Ag nanoparticles prepared using the reducing agent of (I) ascorbic acid, (II) sodium borohydride, (III) hydrazine, and in each graph (a) freshly prepared and (b) after 4 weeks sodium borohydride, and hydrazine. After the colloids have been settled for 4 weeks, the change of the peak absorbance for ascorbic acid is small, although it shifted slightly to a larger wavelength. The peak of absorbance for colloid formed by use sodium borohydride does not change, but it does decrease a little. The peak of the absorbance decreases and shifts considerably for the colloid made by using the reducing agent of hydrazine. The trends for colloids formed by using glucose and sodium citrate are very similar. The stability of the colloid is also critical for long-term use and storage of nanoparticles. Aggregation of nanoparticles to become larger particles will cause the colloid to form a suspension. The change in the UV-Vis spectrum indicates the stability of the colloid. As it was reported, the colloidal porous Pt-Au-Ag nanoparticles may be stable for up to 100 days [10] . Green synthesis of Ag nanoparticles using cowpea seeds can result in colloids that are stable for 11 months [16] . At 50 °C colloidal of Ag nanoparticles-PVA-laccase is known to be stable for up to 13 days only [17] .
CONCLUSION
The reducing agents significantly affect the physical and chemical properties of the Ag nanoparticles regarding shape, size, zeta potential, and stability. The produced colloids in PVA solution have UV-Vis peak absorbance in the range of 401-433 nm. They have an fcc crystal system with a unit cell of 4.0906-4.0992 angstrom. As a reducing agent, ascorbic acid gives spherical shape, the uniform particle diameter of about 20 nm, and zeta potential of -10.4 mV. The colloid of Ag nanoparticles produced by ascorbic acid is also the most stable although it has slightly lower zeta potential than that of colloid obtained by sodium borohydride. The colloids produced using ascorbic acid may find applications for chemical sensors, an antibacterial agent, solar harvesting technology, and so on.
